Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

30

Revenue 2017

Botox/Neuromodulator

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Botox/Neuromodulator was produced by Allergan.

AbbVie creates new aesthetics division amid Allergan takeover

AbbVie creates new aesthetics division amid Allergan takeover Allergan’s leading medical aesthetics business, which most notably includes cosmetic Botox, will now operate as a separate unit – aptly named Allergan Aesthetics. ... This includes psoriasis treatment Skyrizi, Rinvoq, medical Botox, and cancer

Allergan gets FDA nod for first oral CGRP drug for migraine

Allergan gets FDA nod for first oral CGRP drug for migraine established presence in migraine prevention with Botox.

AbbVie sells $30bn of bonds ahead of Allergan merger

AbbVie sells $30bn of bonds ahead of Allergan merger That includes Allergan’s leading medical aesthetics business – with the most notable product being Botox – which earned $3.7bn in revenues last year. ... They highlighted that Allergan’s Botox is currently facing tougher competition in the market

NICE delivers final ‘no’ for Novartis’ migraine treatment Aimovig

NICE delivers final ‘no’ for Novartis’ migraine treatment Aimovig The agency also presented concerns that for the chronic migraine subgroup, there was no direct comparison with the current standard of treatment, botulinum toxin type A (Botox), so its superiority is

AbbVie/Allergan's merger faces public opposition

AbbVie/Allergan's merger faces public opposition Allergan’s biggest product, Botox, is also facing tougher competition in the market from new migraine drugs and rivals in its medical aesthetics indications.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...